Abstract
Alterations in the metabolism of monoamine neurotransmitters have been proposed to be involved in the development of the hepatic encephalopathy (HE) associated with experimental and human liver failure. In order to evaluate this hypothesis, the monoamines and some of their metabolites were measured in homogenates of caudate nucleus (CAU), prefrontal (PFCo) and frontal cortex (FCo) dissected from brains obtained at autopsy from nine cirrhotic patients who had died in hepatic coma and an equal number of control subjects, free from neurological, psychiatric and hepatic disorders, matched for age and time interval from death to freezing of autopsied brain samples. Monoamine measurements were performed by high-performance liquid chromatography with ion-pairing and electrochemical detection after a simple extraction procedure. In all three regions investigated, concentrations of dopamine (DA) were unchanged in cirrhotic patients vs controls while its metabolites, 3-methoxytyramine (3-MT) and homovanillic acid (HVA) were selectively affected i.e.3-MT was found to be increased in CAU, while HVA levels were increased in FCo and CAU. DOPAC was also found to be unchanged in CAU. Noradrenaline (NA) levels were greatly increased in PFCo and FCo of cirrhotic patients but remained unchanged in CAU. No significant differences in the concentrations of either serotonin (5-HT) or of its precursor 5-hydroxytryptophan (5-HTP) were found in any of the three regions studied. However, 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of 5-HT, was increased in PFCo and CAU of cirrhotic patients. These findings show that selective alterations of catecholamine and 5-HT systems are involved in human HE and therefore, they may play an important role in the pathogenesis of certain neurological symptoms associated with this encephalopathy.
Similar content being viewed by others
References
Fischer, J. E., and Baldessarini, R. J. 1971. False neurotransmitters and hepatic failure. Lancet 2:75–80.
Munro, H. N., Fernstrom, J. D., and Wurtman, R. J. 1975. Insulin, plasma aminoacid imbalance, and hepatic coma. Lancet, 1:722–724.
Fischer, J. E., and Baldessarini, R. J. 1976. Pathogenesis and therapy of hepatic coma. Pages 363–397,in Popper, H., Shaffner, F. (eds.), Progress in liver diseases, vol. 5, Grune and Stratton, New York.
Rosen, M. H., Yoshimura, N., Hodgman, J. M., and Fischer, J. E. 1977. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterol. 72:483–487.
Cascino, A., Cangiano, C., Fiaccadori, F., Ghinelli, F., Merli, M., Pelosi, G., Riggio, O., Rossi Fanelli, F., Sacchini, D., Stortoni, M., and Capocaccia, L. 1982. Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Digest. Dis. Sc. 27:828–832.
Bergeron, M., Pomier Layrargues, G., and Butterworth, R. F. 1989. Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Metab. Brain Dis.4:169–176.
Zanchin, G., Rigotti, P., Dussini, N., Vassanelli, P. and Battistin, L. 1979. Cerebral amino acid leveis and uptake in rats after portocaval anastomosis. II. Regional studies in vitro. J. Neurosci. Res. 4:301–310.
Mans, A. M., Biebuyck, J. F., Davis, D. W., and Hawkins, R. A. 1984. Portocaval anastomosis: Brain and plasma metabolite abnormalities and effect of nutritional therapy. J. Neurochem. 43:697–705.
Jeppsson, B., James, J. H., Edvards, L. L., and Fischer, J. E. 1985. Relationship of brain glutamine and brain neutral amino acid concentrations after portocaval anastomosis in rats. Eur. J. Clin. Invest. 15:179–187.
Record, C. O., Buxton, B., Chase, R. A. Curzon, G., Murray-Lyon, I. M., and Williams, R. 1976. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur. J. Clin. Invest. 6:387–394.
Knott, P. J., and Curzon, G. 1975. Tryptophan and tyrosine disposition and brain tryptophan metabolism in acute carbon tetrachloride poisoning. Biochem. Pharmacol. 24:963–966.
Mans, A. M., Saunders, S. J., Kish, R. E., and Biebuyck, J. F. 1979. Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat. J. Neurochem. 32:285–292.
Jonung, T., Ramzy, A., Herlin, P., James, J. H., Edwards, L., and Fischer, J. E. 1985. Indole amines and amino acids in various brain regions after infusion of branched chain amino acids into hepatectomized rats. Eur. Surg. Res. 17:83–90.
Curzon, G., Kantamaneni, B. D., Fernando, J. C., Woods, M. S., and Cavanagh, J. B. 1975. Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J. Neurochem. 24:1065–1070.
Bengtsson F., Gage, F. H., Jeppsson, B., Nobin, A., and Rosengren, E. 1985. Brain monoamine metabolism and behavior in portacaval-shunted rats. Exp. Neurol. 90:21–35.
Mans, A. M., and Hawkins, R. A. 1986. Brain monoamines after portacaval anastomosis. Metab. Brain Dis. 1:45–52.
Mans, A. M., Consevage, M. W., De Jospeh, M. R., and Hawkins, R. A. 1987. Regional brain monoamines and their metabolites after portacaval shunting. Metab. Brain Dis. 2:183–193.
Bugge, M., Bengtsson, F., Nobin, A., Jeppsson, B., Jonung, T., and Herlin, P. 1988. Serotonin metabolism in the rat brain following ammonia administration. Pages 466–461,in Soeters, P. B., Wilson, J. H. P., Meijer, A. J., and Holm, E. (eds.), Advances in ammonia metabolism and hepatic encephalopathy, Elsevier Science Publishers, Amsterdam.
Bugge, M., Bengtsson, F., Nobin, A., Jeppsson, B., and Herlin, P. 1987. The turnover of brain monoamines after total hepatectomy in rats infused with branched chain amino acids. World J. Surg. 11:810–817.
Dodsworth, J. M., James, J. H., Cummings, M. G., and Fischer, J. E. 1974. Depletion of brain norepinephrine in acute hepatic coma. Surgery, 75:811–820.
Siemert, G., Nobin, A., Rosengren, E., and Vang, J. 1978. Neurotransmittor changes in the rat brain after portacaval anastomosis. Eur. Surg. Res. 10:73–85.
Kamata, S., Okada, A., Watanabe, T., Kawashima, Y., and Wada, H. 1980. Effects of dietary amino acids on brain amino acids and transmitter amines in rat with a portacaval shunt. J. Neurochem. 35:1190–1199.
Cuilleret, G., Pomier Layrargues, G., Pons, F., Cadilhac, J., and Michel, H. 1980. Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy. Gut, 21:565–569.
Herlin, P. M., James, J. H., Nachbauer, C. A., and Fischer, J. E. 1983. Effect of total hepatectomy and administration of branchedchain amino acids on regional norepinephrine, dopamine and amino acids in rat brain. Ann. Surg. 198:172–177.
Knell, A. J., Davidson, A. R., Williams, R., Kantamaneni, B. D., and Curzon, G. 1974. Dopamine and serotonin metabolism in hepatic encephalopathy. Brit. Med. J. 1:549–551.
Smith, A. R., Rossi-Fanelli, F., Ziparo, V., James, J. H., Perelle, B. A., and Fischer, J. E. 1978. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann. Surg. 187:343–350.
Young, S. N., and Lal, S. 1980. CNS tryptamine metabolism in hepatic coma. J. Neural Transm. 47:153–161.
De Armond, S. J., Fusco, M. M., and Dewey, M. M. 1976. Structure of human brain: A photographic atlas., 2nd ed., Oxford University Press, New York.
Reader, T. A., and Grondin, L. 1987. Distribution of catecholamines, serotonin, and their major metabolites in the rat cingulate, piriform-entorhinal, somatosensory, and visual cortex: a biochemical survey using high-performance liquid chromatography. Neurochem. Res. 12:1087–1097.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randell, R. J. 1951. Protein measurement with Folin regent. J. Biol. Chem. 193:265–275.
Joyce, D. 1962. Changes in the 5-hydroxytryptamine content of rat, rabbit and the human brain after death. Brit. J. Pharmacol. 18:370–380.
Wiesel, F.-A., and Sedvall, G. 1974. Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography. Brain Res. 65:547–550.
Solviter, R. S., and Connor, J. D. 1977. Postmortem stability of norepinephrine, dopamine, and serotonin in rat brain. J. Neurochem. 28:1129–1131.
Carlsson, A., and Winblad, B. 1976. Infuence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J. Neural Trans. 38:271–276.
Bucht, G., Adolfsson, R., Gottfries, C. G., Roos, B.-E., and Wibblad, B. 1981. Distribution of 5-hydroxytryptamine and 5-hydroxyindolecetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J. Neural Transm. 51:185–203.
Carlsson, A., Svennerholm, L., and Winblad, B. 1980. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiat. Scand. 61:suppl (280), 75–85.
Gottfries, C.-G., Rosengren, A. M., Rosengren, E. 1965. The occurence of the homovanillic acid in human brain. Acta Pharmacol. Toxicol. 23:23–40.
Adolfsson, R., Gottfries, C.-G., Roos, B.-E., and Winblad, B. 1970. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transm. 45:81–105.
Korpi, E. R., Goodman, S. I., Kleinman, J. E., and Wyatt, R. J. 1987. Relationship between tryptophan and serotonin concentrations in postmortem human brain. Med. Biol. 65:217–220.
Hardy, J. A., Wester, P., Backstrom, I., Gottfries, J., Oreland, L., Stenstrom, A., and Winblad, B. 1987. The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brain. Neurochem Int. 10:445–450.
Wester, P., Gottfries, J., and Winblad, B. 1987. Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metboolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J. Chromato. 415:275–288.
Gottfries, C. G., Roos, B. E., and Winblad, G. 1974. Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material. Acta Psychiat. Scand. 50:496–507.
Cummings, M. G., Soeters, P. B., James, J. H., Keane, J. M., and Fischer, J. E. 1976. Regional brain indoleamine metabolism following chronic portocaval anastomosis in the rat. J. Neurochem. 27:501–509.
Jouvet, M. 1972. The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergebn. Physiol. 64:163–307.
Beaubernard, C., Salomon, F., Grange, D., Thangapregassam, M. J., and Bismuth, J. 1977. Experimental hepatic encephalopathy. Changes of the level of wakefulness in the rat with portocaval shunt. Biomedecine, 27:169–171.
Kurtz, D., Zenglein, J. P., Imler, M., Girardel, M., Grinspan, G., Peter, B., and Rohmer, F. 1972. Etude du sommeil nocturne au cours de l'encéphalopathie porto-cave. Electroenceph. Clin. Neurophysiol. 33:167–178.
Zieve, L. 1982. Hepatic encephalopathy. Pages 433–459,in Schiff, L., and Schiff, E. R. (eds.), Diseases of the liver, Lippincott, Philadelphia.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergeron, M., Reader, T.A., Layrargues, G.P. et al. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 14, 853–859 (1989). https://doi.org/10.1007/BF00964814
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964814